Nuvalent (NUVL) Current Assets (2020 - 2026)
Nuvalent (NUVL) posted Current Assets of $1.3 billion for Q1 2026, down 6.07% on a QoQ basis from $1.4 billion in Q4 2025, and up 20.37% year-over-year from $1.1 billion in Q1 2025.
Nuvalent (NUVL) Current Assets (2020 - 2026) Analysis & Trends
Nuvalent's Current Assets history runs 7 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- Quarterly Current Assets rose 20.37% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 20.37% YoY) and the FY2025 annual result came in at $1.4 billion, up 22.96% from the prior year.
- Current Assets was $1.3 billion for Q1 2026 at Nuvalent, down from $1.4 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.4 billion in Q4 2025 and bottomed at $245.2 million in Q3 2022.
- A 5-year average of $749.3 million and a median of $699.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets slipped 19.63% — and 2024, when it surged 181.03%.
- Nuvalent's Current Assets stood at $478.0 million in 2022, then soared by 51.99% to $726.5 million in 2023, then soared by 55.88% to $1.1 billion in 2024, then gained by 22.96% to $1.4 billion in 2025, then retreated by 6.07% to $1.3 billion in 2026.
- Business Quant data shows NUVL's Current Assets at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $956.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 1.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 956.95 Mn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.09 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 666.26 Mn |
| Mar 31, 2024 | 699.49 Mn |
| Dec 31, 2023 | 726.49 Mn |
| Sep 30, 2023 | 419.77 Mn |
| Jun 30, 2023 | 436.99 Mn |
| Mar 31, 2023 | 456.29 Mn |
| Dec 31, 2022 | 477.99 Mn |
| Sep 30, 2022 | 245.25 Mn |
| Jun 30, 2022 | 258.82 Mn |
| Mar 31, 2022 | 274.47 Mn |
| Dec 31, 2021 | 290.63 Mn |
| Sep 30, 2021 | 305.14 Mn |
| Jun 30, 2021 | 139.28 Mn |